Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2012
05/31/2012US20120136141 Integrin Heterodimer And A Subunit Thereof
05/31/2012US20120136140 Anti-cadherin antibody
05/31/2012US20120136073 Amine-Containing Transfection Reagents and methods for making and using same
05/31/2012US20120135912 Polypeptide inhibitors of vla4
05/31/2012US20120135879 Method and Composition for Cancer Diagnosis and Treatment
05/31/2012US20120135538 Agent and method for identifying lysine crotonylation in proteins
05/31/2012US20120135516 Artificial antibody polypeptides
05/31/2012US20120135496 Protein Belonging to the TNF Superfamily Involved in Signal Transduction, Nucleic Acids Encoding Same and Methods of Use Thereof
05/31/2012US20120135447 Nucleic acids encoding t2r, a novel family of taste receptors
05/31/2012US20120135428 Novel markers for chronic kidney disease
05/31/2012US20120135426 Method for quantifying phosphokinase activity on proteins
05/31/2012US20120135422 Anti-gpcr antibody and the method of producing the same
05/31/2012US20120135420 Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof
05/31/2012US20120135024 Neisseria meningitidis antigens and compositions
05/31/2012US20120135022 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essentially consisting of vp3
05/31/2012US20120135020 Ttk peptides and vaccines including the same
05/31/2012US20120135018 Erg monoclonal antibodies
05/31/2012US20120135012 Trans-membrane-antibody induced inhibition of apoptosis
05/31/2012US20120135011 Method for in vivo expansion of T regulatory cells
05/31/2012US20120135009 Cleaved and Phosphorylated CRMP2 as Blood Marker of Inflammatory Diseases of the Central Nervous System
05/31/2012US20120135008 Methods and compositions for targeting polyubiquitin
05/31/2012US20120135006 Ultra high affinity neutralizing antibodies
05/31/2012US20120135005 ANTI-TNF-a ANTIBODIES AND THEIR USES
05/31/2012US20120135004 Antibodies to matrix metalloproteinase 9
05/31/2012US20120135003 Anti-ilt7 antibody
05/31/2012US20120134997 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
05/31/2012US20120134992 Mesothelin antibody protein fusions and methods of use
05/31/2012US20120134985 Methods for modulating metabolic and circadian rhythms
05/31/2012US20120134984 Molecules with extended half-lives and uses thereof
05/31/2012US20120134983 Method for Identifying Interventions that Control the Translational Activity of Ribosomal Proteins in Different MRNA Expression
05/31/2012US20120134956 Colloidal metal compositions and methods
05/31/2012US20120134927 Beta cell marker antibody
05/31/2012US20120134920 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules
05/31/2012CA2856565A1 Compositions and methods
05/31/2012CA2818689A1 Novel signal sequences to improve protein expression and secretion of recombinant enzymes and other proteins
05/31/2012CA2818621A1 Multispecific antigen binding proteins targeting hgf
05/31/2012CA2818534A1 Antigen binding proteins
05/31/2012CA2818426A1 Human antibodies to the glucagon receptor
05/31/2012CA2817415A1 Antibodies that bind notum pectinacetylesterase
05/30/2012EP2458013A1 Anti alpha v beta 6 antibodies and uses therof
05/30/2012EP2458012A1 Anti alpha v beta 6 antibodies and uses thereof
05/30/2012EP2457930A1 Modified chaperonin 10
05/30/2012EP2457929A1 ELISA for VEGF
05/30/2012EP2457928A2 Monoclonal human tumor-specific antibody
05/30/2012EP2457587A1 Anitbodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
05/30/2012EP2457586A1 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
05/30/2012EP2457585A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/30/2012EP2457439A1 Transgenic non-human animals for producing specific isotypes of human antibodies via non-cognate switch regions
05/30/2012EP2457096A2 Phenotyping tumor-infiltrating leukocytes
05/30/2012EP2456790A1 Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
05/30/2012EP2456789A1 Optimizing the production of antibodies
05/30/2012EP2456464A1 Methods of treating her2 positive cancer with her2 receptor antagonist in combination with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
05/30/2012EP2456456A1 Methods and compositions for treating neuronal damage or degeneration
05/30/2012EP2195345B1 Monoclonal antibody which binds met in formalin-fixed and paraffin-embedded tissues and related methods
05/30/2012EP2078531B1 Pharmaceutical compositions and methods useful for modulating angiogenesis
05/30/2012EP1947460B1 Method of measuring ptx3 with high sensitivity
05/30/2012EP1866337B1 Method for obtaining antibodies
05/30/2012EP1575516B1 Chimeric and humanized antibodies to alpha5 beta1 integrin that modulate angiogenesis
05/30/2012EP1405079B1 Modulation of the interaction between evh1 domains
05/30/2012EP1283057B2 Cell proliferation inhibitors
05/30/2012CN1985000B T-cell death-inducing epitopes
05/30/2012CN1914322B Cell expansion lethal toxin and detection of bacterium belonging to campylobacter genus that targets the same
05/30/2012CN1901930B Integrin alphaiibbeta3 specific antibodies and peptides
05/30/2012CN1896102B Anti-hbs monoclonal antibodies
05/30/2012CN1886506B Protein expressed in nk cell
05/30/2012CN1852976B Binding constructs and methods for use thereof
05/30/2012CN1852730B Modulators of P-selectin glycoprotein ligand 1
05/30/2012CN1798766B Humanized antibodies that recognize beta amyloid peptide
05/30/2012CN102482646A 幽门螺杆菌脂多糖外部核心表位 Helicobacter pylori lipopolysaccharide external core epitope
05/30/2012CN102482357A Humanized anti-cdcp1 antibodies
05/30/2012CN102482356A 针对toll样受体2的人源化的抗体及其用途 For toll-like receptor 2 humanized antibodies and uses thereof
05/30/2012CN102482355A Antibodies
05/30/2012CN102482354A Anti ceacam1 antibodies and methods of using same
05/30/2012CN102482353A 特异于钙粘素-17的抗体 Cadherin antibody specific for -17
05/30/2012CN102482352A Antibodies against il-17br
05/30/2012CN102482351A Anti-c[epsilon]mx antibodies capable of binding to human mige on b lymphocytes
05/30/2012CN102482350A Antibodies against glucagon receptor and their use
05/30/2012CN102482349A 抗vegf抗体和其用途 Anti-vegf antibodies and their use
05/30/2012CN102482348A Collagen neoepitope antibody
05/30/2012CN102482347A Modified antibody compositions, and methods of making and using thereof
05/30/2012CN102482346A 对甲氧西林抗性金黄色葡萄球菌特异的抗体及将其用于甲氧西林抗性葡萄球菌的检测方法和试剂盒 Methicillin-resistant Staphylococcus aureus-specific antibody, and methicillin-resistant staphylococci detection method and kit for use in
05/30/2012CN102482345A 针对流感病毒的中和分子 Against the influenza virus and molecular
05/30/2012CN102482344A 速度因子 Speed ​​Factor
05/30/2012CN102482343A 过氧化物氧还蛋白4的诊断应用 Diagnostic applications thioredoxin peroxidase 4
05/30/2012CN102482342A Soluble "heavy-chain only" antibodies
05/30/2012CN102482331A 用于检测和鉴别样品中变异艰难梭菌菌株的方法 The method of detection and identification of samples for C. difficile strain variation
05/30/2012CN102481380A 体内肿瘤血管系统成像 In vivo imaging of tumor vasculature
05/30/2012CN102481373A Drug fusions and conjugates
05/30/2012CN102481367A Bi-specific digoxigenin binding antibodies
05/30/2012CN102481366A 用于治疗癌症的针对cdcp1的抗体 For the treatment of cancer, an antibody against cdcp1
05/30/2012CN102481365A Method of treating cancer with dll4 antagonist and chemotherapeutic agent
05/30/2012CN102481341A Proproteins and methods of use thereof
05/30/2012CN102481340A 干细胞靶向 Stem cell targeting
05/30/2012CN102477412A 抗猪细小病毒单克隆抗体及应用 Monoclonal antibodies against porcine parvovirus and Applications
05/30/2012CN102477097A 一种氯霉素单克隆抗体的制备方法 A method for preparing a monoclonal antibody chloramphenicol
05/30/2012CN102477096A 分子伴侣功能的人肌酸激酶单链抗体 Chaperone function of human single-chain antibody creatine kinase
05/30/2012CN102477095A 一种抗活化巨噬细胞多克隆抗体的制备及对败血症的作用 An anti-activated macrophages polyclonal antibody preparation and the role of sepsis
05/30/2012CN102477085A 白念珠菌生长相关因子Cas5突变体的构建和应用 Candida albicans growth-related factor Cas5 mutation body construction and application
05/30/2012CN102115732B Anti-rat ATF3 (activating transcription factor 3) monoclonal antibody secreted by hybridoma cell strain WXR
05/30/2012CN101914159B Polyclonal antibody performing specific antigen-antibody reaction with CP4-EPSPS protein and application thereof
1 ... 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 ... 1494